Malocclusion Market Analysis, Trends and Opportunities 2022 - 2027

 Malocclusion Market

The global malocclusion market is expected to grow at a CAGR of 7.0% during the forecast period.

Malocclusion is the misalignment of teeth. Malocclusion is most often hereditary, but it can also occur due to other reasons i.e. childhood habits such as thumb sucking, pacifier use beyond age 3, and others, extra teeth or lost teeth, ill-fitting dental fillings, and jaw tumors. There are three major classes of malocclusion i.e. Class 1, Class 2, and Class 3.

Increasing prevalence of malocclusion, favorable reimbursement scenario, and rising trend of cosmetic dentistry are the key factors driving the malocclusion market.

However, lack of technological awareness and complications associated with malocclusion treatment may hinder the growth of the market to an extent. The lack of technological awareness is mainly attributed to the slow adoption rate of new technology by the dentists.

Taste the market data and market information presented through more than 296 market data tables and figures spread over 251 pages of the project report.

Major Key Players:

Some of key the players in the malocclusion market are 3M, A-dec Inc., Adenta GmbH, Align Technology, Inc, American Orthodontics, Biolase, Inc., Carestream Health, Inc., Danaher, DENTAURUM GmbH & Co. KG, Dentsply Sirona, G&H Orthodontics, Henry Schein, Inc., Midmark Corp., Patterson Companies, Inc., Planmeca OY, Rocky Mountain Orthodontics, Septodont Holding, TP Orthodontics, Inc, Ultradent Products Inc., Zimmer Dental Inc., and others.

Segment Analysis

The global malocclusion market is segmented on the basis of class, treatment, and end user.

On the basis of the class, the market is classified into class I, class II, and class III.

On the basis of the treatment, the market is segmented into orthodontic braces, surgery, and others. The orthodontic braces segment is further sub-segmented into metal braces, ceramic braces, clear aligner, and others.

On the basis of the end -users, the market is segmented into the hospital and clinics, dental clinics, and others.

Regional Analysis

The Americas dominate the malocclusion market owing to the improvement in reimbursement scenario, high healthcare expenditure, and the presence of the leading players in the region. According to the American Dental Association, in the United States, Maryland, Utah, Arkansas, and Massachusetts have the highest Medicaid FFS reimbursement rates i.e. 79.3%, 75.3%, 75.2%, and 74.1% respectively, whereas, Wisconsin, California, Washington, Maine, and Iowa have the lowest coverage relative to private dental insurance reimbursement rates.

Europe holds the second position in the malocclusion market. It is expected that the support provided by the government bodies for research & development, increasing healthcare expenditure, and rising prevalence of malocclusion are propelling the growth of the malocclusion market in the European region. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and then United Kingdom with EUR 223 billion.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.

The Middle East and Africa hold the least share of the malocclusion market owing to the presence of poor and slow developing countries, especially, in the African region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare RFID Market Strategy, Regional Analysis and Growth Forecast to 2027

 Healthcare RFID Market

Radiofrequency identification (RFID) is used for patient monitoring, efficiencies in patient care, tracking, and provider satisfaction. RFID is a wireless system that exploits radio waves for collecting data from a tag attached to an object, for several purposes such as automatic identification, and tracking of objects.

The rising concerns about inventory management, awareness about patient safety, and increasing acceptance of automation in the healthcare sector are the major factors driving the growth of the global healthcare RFID market. Additionally, aggressive strategies adopted by the top players and the introduction of new products in the market are fueling the growth of the market during the forecast period. For instance, Alien Technology Corporation, a leader in RFID technology introduced RFID Reader with the ALR-F800-X, the product is known for its use in maintaining the workflow and efficiently handling the data. Also, the company is trying to expand its geographical boundaries by signing distribution agreements.

The high costs associated with the RFID products and lack of awareness about the RFID in developing countries are likely to hinder market growth during the forecast period.

Major Key Players:

Some of the key players in the global healthcare RFID market are Alien Technology Corporation, Applied Wireless Identifications Group, Inc., CAEN RFID S.r.l., Gao RFID, Inc., Honeywell International Inc., Impinj Inc., Invengo Information Technology Ltd. Co., Mobile Aspects, Inc., Motorola Solutions, Inc., Radianse, RF Technologies, Stanley Healthcare, and STiD RFID

Segment Analysis

The global rfid in healthcare market has been segmented on the basis of component, application, end user, and region.

On the basis of component, the market has been segmented into tags, readers, middleware, printers, and others. The tags segment is further divided into active tags and passive tags. The reader segment is further segmented into active reader and passive reader.

The global healthcare RFID market, by application, has been segmented into equipment tracking, people identification and tracking, medical report and blood samples tracking medicine tracking, and others.

On the basis of end user, the market has been classified as pharmaceutical and biotechnology companies, hospitals, research institutes, and others.

Regional Analysis

The market is likely to dominate by Americas during the forecast period owing to the increasing prevalence of cancer patients, increasing cases of drug counterfeiting, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support of the healthcare sector, raising awareness about the innovative technologies, and improvement in the healthcare sector with respect to infrastructure and facilities. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological development, the increasing prevalence of chronic diseases, rising investments in healthcare and expansions by market players in the region. The market in the Middle East & Africa is likely to account for the smallest share of the global healthcare RFID market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Malaria Diagnostics Market 2022 Global Opportunities and forecast to 2027

 Malaria Diagnostics Market

The malaria diagnostics market is expected to grow at 4.6% CAGR during the forecast period

Primary and precise diagnosis of malaria is essential for both fast and effective disease management and observation. Superior quality malaria diagnosis systems are important in all settings as misdiagnosis or misinterpretation can result in substantial morbidity and mortality. World Health Organization (WHO) recommends a quick malaria diagnosis either by microscopy or malaria rapid diagnostic test (RDT) in all patients with suspected malaria before treatment is being administered. Diagnostic testing improves the overall management of patients with febrile illnesses and may also help to decrease the emergence and spread of drug resistance by storing antimalarials for those who have the disease. The scope of malaria diagnostics is growing rapidly with technological advancements and a growing number of investments. Also, growth in a number of hospitals and healthcare facilities, and initiatives taken by the government are the major factors driving the growth of the malaria diagnostics market.

However, the dearth of appropriate monitoring standards at the country levels particularly in developing markets hinders the growth of the market. The weak regulatory framework and lack of awareness across the emerging nations is also a prime concern for the manufacturers and healthcare providers.

Major Key Players:

Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.

Segment Analysis

The global malaria diagnostics market has been segmented on the basis of technology and end-user.

On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR). On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.

Regional Analysis

The Americas is projected to lead the malaria diagnostics market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market.  

The European market is expected to hold the second largest market share. The European market is projected to grow because of the malaria cases brought in the European region by tourists and refugees. The European Centre for Disease Prevention and Control, stats reported a range of 5000 -7000 cases of malaria from 2008 to 2012.

Asia-Pacific is projected to be the fastest growing region for the global malaria diagnostics market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. The diagnostic testing market, by volume, in India is controlled by microscopy testing. With increasing awareness and growing funding from care-based surveillance systems, private sectors and national governments the necessity for diagnostic testing procedures are projected to rise, thereby boosting the market development.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income. Southeast Asia accounted for about 10% of the global cases, however, the death rate was around 7% in the same year.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Artificial Eye Market Regional Analysis, Key Players, Opportunities and Forecast to 2027

 Artificial Eye Market

Artificial Eye Market is projected to be worth USD 24.8 Million by 2028, registering a CAGR of 9.6% during the forecast period

Artificial eye is an ocular prosthesis that replaces an absent natural eye following an enucleation, evisceration, or orbital exenteration. It fits over an orbital implant and under the eyelids. Increasing number of visually impaired people worldwide has encourage many of the manufacturer for introduction of the new and better treatment for ophthalmic problems. According to WHO, the number of people suffering optic problem are increasing and approximately 90% of the patients are present in developing countries. Increasing number of people suffering from diabetes and rising geriatric population has driven the growth of the market. Beside this development in technology and increasing healthcare expenditure has provided fuel for the growth of the market. On the other hand, high cost, limited surgical professionals and availability of alternative therapy has hindered the growth of the market.

Major Key Players:

The key players for the global artificial eye market are Advanced Artificial Eye (US), The National Artificial Eye Services (NHS) (UK), Marie Allen Ocularist Ltd (Canada), COS-MEDIC PTY LTD (Australia), Retina Implant AG (Germany), Second Sight (US), Pixium Vision (France), Ericksons Custom Made Artificial Eye (Canada), International Prosthetic Eye Center (India)

Segment Analysis

Global artificial eye market is segmented on the basis of type, non-integrated implants, Integrated implants. Integrated implants are further segmented into hydroxyapatite, porous polyethylene, bioceramic, conical orbital implant and other. On the basis of technology, they are segmented into electronic and mechanical and on the basis of end user, the market is segmented into hospitals, ophthalmology clinics and others

Regional Analysis

Geographically, Global artificial eye market is dominated by America which is followed by Europe. Asia Pacific is the fastest growing market for artificial eye. Presence of number of developing economies and increasing aging population in Asia Pacific has boosted the growth of the market. Japan and Australia are the major contributor for the market. According to International Agency for the Prevention of Blindness, 7.6% population in Japan is suffering from diabetes and the prevalence of visual impairment is increasing at the rate of 1.5%. This increasing number of patient and well developed economy has provided support for the growth of the market in Japan. India and China has developing market for artificial eye. Middle East & Africa has the least market for the artificial eye. Majority of countries in Africa are poor and people are not able to afford the cost of treatment which has restrained the growth in this region, however Middle East countries like UAE, Kuwait and Qatar are very rich & developed countries, and also the major contributor for the market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Metagenomic Sequencing Market 2022 Size, Share, Growth, Opportunities and forecast to 2027

 Metagenomic Sequencing Market

Metagenomics sequencing, also known as environmental or community genomics is an approach that allows insight to be gained into community biodiversity and function. In the process of metagenomics sequencing, the DNA of the specified host microorganism is extracted and cloned directly from the microorganism using genetic analyses of DNA.

The function of metagenomic sequencing which is to sequence the genomes of untargeted cells in a community in order to elucidate community composition and function helps to understand the several types of cells in a community and what organisms are present in their physiology.

Research using the metagenomic sequencing taps into several fields due to the broad existence of large microbial communities. For instance; the study of soil microbiota has led to advances in understanding and treating plant pathogens. Whereas. In human gut microbiota, the use of metagenomics discovered how common antibiotic genes are in the gut bacteria.

Currently, the metagenomic sequencing market is growing pervasively. The dominant factors driving this growth include the rising awareness of genetic disorders, advanced technological platforms, and the availability of improved genomic tools. Moreover, the continually dropping prices of this process are escalating the market on the global platform, encouraging people to undergo the genetic tests.

Acknowledging the exponential growth this market is witnessing today, Market Research Future (MRFR), in its recently published study report asserts that the global metagenomic sequencing market will further garner enormous gains by 2023, registering approximately 6.5% CAGR throughout the forecast period (2017 – 2023).

The market demonstrates vast opportunities for service providers and companies with a great scope of expanding to enter the untapped regions by making these procedures affordable.

Additional factors fostering the growth of the market include the use of advanced bioinformatics tools, high throughput screening (HTS) methods, recovery of novel drugs, and the development of cost-effective technologies such as next-generation sequencing (NGS).

Major Key Players:

Players leading the global metagenomic sequencing market include Enterome Bioscience (France), GATC Biotech AG (Germany), Aperiomics, Inc. (U.S.), Illumina Inc. (U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland), Second Genome Therapeutics (U.S.), SciGenom Labs Pvt. Ltd. (India),  Quest Diagnostics Incorporated (U.S.), GenapSys, Inc. (U.S.), Freenome Inc. (U.S.), COSMOSID (U.S.), Beijing Genomics Institute (China), Pacific Biosciences (U.S.), Biomatters Ltd. (New Zealand), Oxford Nanopore Technologies Inc. (UK), Thermo Fisher Scientific Inc. (U.S.), CLC Bio (Qiagen) (Denmark), DNAStar Inc. (U.S.), Agilent Technologies Inc. (U.S.), Macrogen Inc. (South Korea), Knome Inc. (U.S.), and Helicos BioSciences (U.S.) among others.

Segment Analysis

MRFR has segmented the report into four key dynamics for an easy grasp;

By Technology: Sequencing and Bioinformatics among others.

By Application : Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Ecology, and Agriculture among others.

By End-user : Hospitals, Research Institutes, and Specialized Clinics among others.                                                                 

By Regions :  North America, Europe, Asia Pacific, and the Rest-of-the-World (RoW).

Regional Analysis

The North American region leads the global metagenomic sequencing market owing to the presence of global players who are focused on introducing the procedures with innovative technology. Encouraging governmental support for R&D activities in healthcare and metagenomic sequencing tests is acting as a significant tailwind that is pushing up the market.

Additional factors encouraging the growth of the market include increased uptake of advanced technologies in the next generation sequencing procedures and its increasing applications and high healthcare expenditures.

The metagenomic sequencing market in the US backed the increasing demand for metagenomic sequencing, contributes to the growth of the regional market majorly. Heading with the rising demands for metagenomic sequencing procedures, the region will create a larger revenue pocket in the global metagenomic sequencing market by 2023.

Heading with the significant advancements of technologies and their wide uptake in the medical sector, the metagenomic sequencing market in the European region holds the second position in terms of size.

Moreover, the presence of a flourishing medical devices market and rising healthcare expenditure in the region will facilitate the growth of the market. Also, factors such as support and funding from public & private sectors for research & development impacts the market growth in the region positively.

Furthermore, the availability of low-cost metagenomic and NGS procedures and their rising adoption by research laboratories are driving the growth of this market.

The Asia Pacific region heading with the increasing prevalence of genetic disorders has emerged as a promising market for metagenomic sequencing. The large unmet clinical needs are attracting the foreign investors and global players to focus on this region to expand the network that is helping them to capture major share of the market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Sentinel Node Biopsy Market Statistics, Trends, Segmentation Analysis and Forecast to 2027

 Sentinel Node Biopsy Market

The global sentinel node biopsy market is growing pervasively mainly due to the increasing prevalence of various types of cancer including melanoma, colon cancer, breast cancer, esophageal cancer, head and neck cancer among others. Moreover, the spreading awareness towards the advantages of sentinel node biopsy escalates its market on the global platform.

Acknowledging the exponential traction, the market is witnessing currently, Market Research Future (MRFR) in its recently published a study report asserts that the global sentinel node biopsy market will witness significant registering 5.1 % CAGR during the review period

Additional factors propelling the growth of the market include the changing lifestyle led by the growing urbanization & industrialization. Improving economic conditions worldwide are defining the growth of the sentinel node biopsy market, enabling access to the quality of life & to the improved healthcare. Furthermore, factors such as increasing number of biopsy procedures and rising demand for new techniques for the diagnosis of cancerous growth provide significant impetus to the market growth.

On the other hand, factors such as prohibitive costs associated with the biopsy and the large unmet need are some of the key factors impeding the market growth, especially in the developing nations. Nevertheless, factors such as the availability of new products and services and the presence of well-established market players in the developing as well as developed countries will support the market growth, filling up the demand and supply gap.

Major Key Players:

Key players leading the global sentinel node biopsy market include Devicor Medical Products, Inc. (Germany), C. R. Bard, Inc. (U.S.), Hilfe Engineering Corporation (India), Intramedical Imaging LLC (U.S.), KUB Technologies, Inc. (U.S.), Surgic Eye (Germany), and Navidea Biopharmaceuticals, Inc. (U.S.) among others.

Segment Analysis

The MRFR analysis is segmented into four key dynamics for enhanced understanding.

By Product          : Breast Localization Wire, Tissue Marker, Gamma Probe, and Drainage Catheters, liquid biopsy among others.

By Indication:  Breast Cancer, Melanoma, Colon Cancer, and Esophageal Cancer among others.

By End-user        : Hospitals & Clinics, and Diagnostic Centers among others.

By Regions          : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Regional Analysis

The North American region, heading with the increasing number of market players offering biopsy devices and instruments, accounts for the leading market for sentinel node biopsy, globally. Factors such as the extensive and early uptake of medical technology for advancing medical devices and the increasing governmental support for R&D activities alongside the high health care expenditures substantiate the market growth in the region.

Furthermore, the increasing number of women suffering from breast disorders and rising prevalence of breast cancer along with the availability of quality care drives the growth of the regional market. With the constant developments by companies operating in cancer diagnostics, the market is expected to create the major revenue pocket during the review period.

The sentinel node biopsies market in the European region led by the increasing emphasis on the development of advent diagnostic devices, accounts for the next largest market, globally. Moreover, factors propelling the growth of the regional market include rising government support with the increased funding for R&D activities in the field of oncology and the rising numbers of specialty services offered by various healthcare providers.

Germany leads the European sentinel node biopsies market owing to an increasing demand for cancer diagnosis.  Whereas France and the U.K heading with the availability of tertiary care facilities in these countries and rising healthcare expenditures, secure second and third position, respectively.

The Asia Pacific region is emerging as a  profitable market for Sentinel Node biopsies, growing rapidly. Increasing incidents of breast cancer is a key driving factor fostering market growth.  Furthermore, factors such as the increasing demand for quality devices in healthcare and rapidly developing healthcare technology are fuelling the market growth in the APAC region, leading to increased use of advanced biopsy equipment.

India and China led by the presence of the highly skilled workforce and the increasing demand for biopsy procedures in hospitals and specialty care centers, exhibit enormous growth opportunities.  Moreover, growing occurrences of chronic diseases, an increase in the number of women suffering for reproductive disorders, and increasing expenditure on surgical procedures in developing economies throughout the APAC foster the growth of the regional market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Biomarker Technologies Market, Opportunities, Size, Share, Trends Analysis and Forecast to 2027

 Biomarker Technologies Market

The biomarker technologies market is expected to reach USD 78 Billion by 2023 at a CAGR of 9% during the forecast period. The term biomarker is usually used to define a measurable indicator of some biological state or condition. It is also referred to a substance whose detection indicates the presence of a living organism. Biomarkers are used for diagnosis and clinical decision making in cancer, diabetes, and cardiovascular and neurological diseases. The market for biomarker technologies is growing worldwide due to drivers such as increased occurrence of above diseases, advances in the area of medical technologies, governmental initiatives supporting research in the area of biomarker technologies, and increasing uses of biomarkers to increase the accuracy of disease diagnosis. However, high capital investments required for the discovery, development of biomarkers, and the high cost of biomarkers are restraining the growth of the biomarker technologies market.

Major Key Players:

Market Research Future (MRFR) recognizes the following companies as the key players in the biomarker technologies market. Some of the players are Abbott Laboratories, Agilent Technologies (U.S.), Thermo Fisher Scientific (U.S.), Roche (Switzerland), Waters Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthcare, and Bio-Rad Laboratories (U.S.).     

Segment Analysis

The global biomarker technology market is segmented on the basis of product type, profiling technology, disease application, and research areas. Considering product type, the market is segmented into consumables, instruments, services, and software/informatics.

By profiling technology, the market is segmented into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. Based on immunoassay, the market is again segmented into ELISA, western blot, and protein microarray.

With reference to disease application, the market is segmented into cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and other disorders.

On account of research areas, the market is segmented into genomic biomarkers, Proteomics, Metabolomics, and other research areas. Metabolomics is further segmented into lipidomic and others.

Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Regional Analysis

Americas has the largest market share in the biomarker technologies market. The increasing prevalence of cancer, cardiovascular diseases, neurological as well as autoimmune diseases, and rising geriatric population are likely to enhance the growth of the biomarker technologies market.  For instance, the National Cancer Institute (NCI) had stated that 1,666,540 new cases of cancer were reported during 2014 in the United States. Thus, this increasing patient pool will enhance the market growth during the forecast period. Additionally, factors such as increasing government initiatives and funding for research and development in advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of the biomarker technologies market in the American region. Furthermore, according to CMS (Centers for Medicare and Medicaid Services) the U.S. health care spending increased by 4.3 percent to reach USD 3.3 trillion per person in 2016. Thus, increasing per capita income of individuals as well as rising healthcare spending will aid up the market growth in Americas.

Europe is the second largest market leader and holds a healthy share in the global biomarker technologies market. The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities and established healthcare infrastructure, along with the growing need for efficient and accurate diagnosis. Furthermore, according to the Cancer Research U.K., there were around 9, 921 cases of cancer diagnosed in 2015. The increasing occurrence of cancer is expected to have a positive impact on the biomarker technologies market due to its wide usage in cancer. This impact will enhance the biomarker technologies market in Europe.

Asia Pacific is expected to be the fastest emerging market. Factors such as the increasing prevalence of chronic diseases are the major driver for the market growth. For instance, in accordance with the International Diabetes Federation, nearly 382 million people had diabetes in 2013 worldwide. This is expected to reach around 500 million by the end of 2035. China and India are the first and second most affected countries with diabetes. This rising number of diabetic patients can lead to the increasing patient number with cardiovascular diseases. So, these countries are expected to be the fastest growing regions due to the increasing patient pool, raising awareness about health, and availability of new treatment methods.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Angiography Equipment Market 2022 Share, Size, Trend, Market Analysis and Forecast to 2027

 Angiography Equipment Market 2022

The angiography equipment market is growing rapidly attributing to the increasing number of cases of cardiovascular and coronary diseases, which are the result of changing lifestyle. Over the last three decades, equipment used in angiography procedures have evolved significantly demonstrating remarkable advances. Such betterments are predominantly driving the growth of the market. Also, there has been a remarkable growth in the awareness about coronary diseases and cardiovascular-related surgeries, which is escalating the market on the global platform.

According to Market Research Future (MRFR), the global angiography equipment market is expected to garner notable accruals by 2023. In its recently published research report, MRFR also asserts that the market would register over 5% CAGR throughout the assessment period. Technological advancements in interventional radiology is a key driving force behind the growth of the market.

Additional factors acting as significant growth propellers to the market include the rising prevalence of cardiovascular diseases, increasing numbers of angiography procedures, and benefits of the technique in early diagnosis & treatments. Also, the growing demand for interventional angiography systems in minimally invasive surgeries and rising healthcare expenditures are defining the growing landscape of the market.

On the other hand, limitations in reimbursement for angiographic surgeries and risk of radiation exposure are major growth restraining factors of the market. Nevertheless, factors, such as the improving economic conditions that are increasingly expanding the access to the quality healthcare would support the growth of the angiography equipment market over the assessment period, increasing per-capita healthcare expenses.

Major Key Players:

Players leading the global angiography equipment market include Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Boston Scientific Corporation (US), Canon Corporation (Japan), Cordis, a Cardinal Health Company, (US), Medtronic (Ireland), Shimadzu Corporation (Japan), Angiodynamics (US), Abbott Laboratories (US), B. Braun Melsungen (Germany), and Terumo (Japan), among others.

Segment Analysis

The report is segmented into seven key market dynamics to widen the scope of understanding,

By Product: Angiography Catheters, Angiography Systems, Angiography Contrast Media, Angiography Balloons, Vascular Closure Devices (VCDs), Angiography Guidewires, and Angiography Accessories, fluorescein angiography machine.

By Technology:  CT angiography, X-ray angiography, MR angiography, and other angiography technologies.

By Procedure:Endovascular Angiography, Coronary Angiography, Neuro-Angiography, Onco-Angiography, and other Angiography Procedures.

By Indication: Valvular Heart Disease, Coronary Artery Disease, Congenital Heart Disease, Congestive Heart Failure, and other indications.

By Application: Diagnostics and Therapeutics.

By End-user: Hospitals & Clinics, Diagnostic & Imaging Centers, and Research Institutes.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World.

Regional Analysis

Europe is considered as the leading region in the global angiography equipment market. Factors, such as the high per capita healthcare expenditures and the growing population act as major tailwinds to the regional market growth. Moreover, a well-developed infrastructure, increasing prevalence of cardiovascular disorders, spreading awareness of CABG procedures, and technological advancements are expected to spur the market growth in the region.

Additionally, increasing numbers of angiography procedures and growing preference of minimally invasive devices contribute to the growth of the regional market. Furthermore, the resurging economy is playing a vital role in increasing the value of the regional market, increasing access to quality care. Also, the availability of specialty care services in hospitals & tertiary care centers, increasing demand for the treatment options of cardiovascular diseases, and rising prevalence of cardiovascular diseases escalate the market growth in the region.

Moreover, factors positively impacting the growth of the regional market include the growing emphasis on coronary artery bypass procedures and increasing geriatric population with chronic diseases such as diabetes & obesity which increase the risk for heart disease and cardiovascular diseases.

North America accounts for the second-largest market for angiography equipment, globally. The region witnesses an increasing number of coronary artery bypass procedures. In addition, the increasing expenditure on healthcare and the well-developed healthcare sector are positively impacting the growth of the market. Besides, the presence of state-of-the-art-infrastructure that allows the development of technologies and early adoption of advanced technologies contribute to the growth of the market in this region.

Moreover, high per capita healthcare spending and the growing prevalence of coronary diseases in the region are expected to spur the market growth in the region. Markets in the US and Canada led by the rising number of bypass surgeries lead the regional market. Furthermore, the rapid uptake of advanced technologies and devices in the surgical process is also an essential growth driver of the market.

The Asia Pacific angiography equipment market is emerging as a promising market globally. The region is heading with the rising cases of patients suffering from cardiovascular disease and coronary diseases. Factors, such as the huge growth in the healthcare sector in highly populated countries like India, Japan, and China, can drive regional market growth.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Amblyopia Market Global Market Demand, Opportunities, Top Key Players and Forecast to 2027

 Amblyopia Market 2022

In the latest report on the global amblyopia market, published by Market Research Future (MRFR), it forecast that the market is anticipated to touch a substantial valuation over the review period, as it is likely to grow with a striking CAGR during forecast.

Market Drivers and Barriers

The escalation in number of ophthalmic disorders cases is observed to surge the global amblyopia market. Amblyopia, generally known as lazy eye, mostly develops in childhood. The lack of awareness regarding the onset of amblyopia often leads to severe complications like blindness, with age. Hence, the growing number of undiagnosed incidences are likely to impel the global amblyopia market growth. Furthermore, this is triggering an urgency in the need for early diagnosis. Consequently, an upsurge in the market growth can be expected due to the availability of advanced ophthalmic diagnostic solutions. The market can also experience an amplified growth over the assessment period owing to the hike in per capita income and increase in medical assistance from the government.

The high cost of treatment due to limited treatment options can constraint the amblyopia market growth, despite the presence of such potent market drivers.

Major Key Players:

The major players operating the global amblyopia market are McKesson Corporation, Johnson & Johnson, Vivid Vision Inc., Good-Lite Co, Carl Zeiss AG, Amblyotech Inc, Novartis AG., Amblyoptica (Holding) Pvt. Ltd, HOYA Corporation, Krafty Eye Patches¸ Fresnel Prism and Lens Co., Hilco Vision, Cooper Vision, and more.

Segment Analysis

The global amblyopia market has been segmented on the basis of type, treatment, diagnosis, end-user, and region.

By types of amblyopia, the global amblyopia market has been segmented into strabismus amblyopia, reverse amblyopia, deprivation amblyopia, refractive amblyopia, and others. Among these, strabismus amblyopia is the most common type and is mainly caused due to suppression of the misaligned or deviating eye.

By mode of diagnosis, the global amblyopia market has been segmented into photo screening, visual acuity tests, Bruckner test, and others.

By mode of treatment, the global amblyopia market has been segmented into video game, atropine drops, glasses, eye patches, and others. Among these, eye patches hold the largest market share and are anticipated to expand at 3.93 % CAGR during the assessment period.

By mode of end-users, the global amblyopia market has been segmented into ophthalmic clinics, hospitals & pharmacies, and others.

Regional Analysis

Geographically, the amblyopia market span across regions namely, Europe, America, Asia Pacific, and the Middle East and Africa.

Among all the regions, America accounts for the largest market share owing to increasing prevalence of ophthalmological disorders such as macular degeneration, cataract, and glaucoma, growth in technological advancements, presence of key market players, and high expenditure on healthcare.

Europe is considered to be the second largest market followed by Asia Pacific which is presumed to expand at the fastest rate with 4.35 % CAGR during the assessment period. The growth is attributed to the continuously growing economies, rapid technological development, presence of huge patient population, and high opportunity for development in this region.

On the other hand, the Middle East and Africa are considered to register a sluggish growth rate and account for the least market share during the review period owing to low income among the population.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Acute Coronary Syndrome Market 2022 Global Industry - Key Players, Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2027

 Acute Coronary Syndrome Market

The escalating stress levels have caused a sharp spike in the number of cases detected in relation to heart diseases. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been currently published along with a report on this industry. Acute Coronary Syndrome Market is projected to develop with a CAGR of 10.4% in the forecast period.

Factors such as increased consumption of food that is saturated with fat, smoking, alcohol consumption and increasing prevalence of sedentary lifestyle are accredited with the rise in the cases of acute coronary syndrome cases in the forecast period. Growing research and development in the market is expected to reinforce the market expansion in the forecast period positively.

Major Key Players:

The strategic competitors in the acute coronary syndrome market are Johnson & Johnson Services, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Boehringer Ingelheim International GmbH (Germany), Portola Pharmaceuticals, Inc. (U.S.), AbbVie Inc.  (U.S.), Bayer AG (Germany), AstraZeneca (U.K), Eli Lilly and Company (U.S.), Amgen Inc. (U.S.), Merck & Co., Inc. (U.S.), GlaxoSmithKline Plc. (U.K), Daiichi Sankyo Company, Limited (Japan), Sanofi (Paris), Novartis AG (Switzerland), and others.

Segment Analysis

The acute coronary syndrome market globally is segmented on the basis of treatment, diagnosis, type, and end-user. On the basis of end-user, the market is segmented into academic institutes, diagnostic centers, hospitals and clinics, and others. By type, the market is segmented into Non-ST-Elevation Myocardial Infarction (NSTEMI), ST-Elevation Myocardial Infarction (STEMI), unstable angina, and others. By diagnosis, the market is segmented into imaging, stress test, blood tests, and others. The imaging segment is further sub-segmented into Computerized Tomography (CT) angiogram, Myocardial Perfusion Imaging (MPI), coronary angiogram, echocardiogram, and others. On the basis of pathophysiology of acute coronary syndrome treatment is segmented into surgery, medication, and others. The medication segment is sub-segmented into nitroglycerin, thrombolytics, antiplatelet drugs, beta blockers, surgery, statins, and others. The antiplatelet drugs segment is further segmented into clopidogrel, aspirin, prasugrel, and others. The beta blockers segment is moreover segmented into nadolol, metoprolol, and others. The statins segment is additionally segmented into simvastatin, atorvastatin, and others. The surgery segment is sub-segmented into coronary bypass surgery, angioplasty and stenting, and others.

Regional Analysis

The regional analysis of the market states that the Americas dominates the global acute coronary syndrome market owing to the rising prevalence of coronary heart diseases and the presence of a well-developed healthcare sector within the region. Furthermore, growing healthcare expenditure and the presence of market players within the region boost the market. The European region comes in second in the acute coronary syndrome market owing to the growing availability of funds for research, a well-developed healthcare sector, and a huge patient population. The Asia Pacific region is the fastest rising region for the market owing to the incidence of emerging economies such as China, India, Australia, and others within the region.

Furthermore, a vast patient population, intensifying healthcare expenditure, and a quickly emerging healthcare sector that will fuel the market development in the forecast period. The Middle East and African region have the minimum share in the acute coronary syndrome market. This can be accredited to the low per capita health care spending and strict government policies, particularly within the African region. Conversely, the Middle East holds a chunk of the market owing to huge healthcare expenditure and a well-developed healthcare sector.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com